NCT05714007View on ClinicalTrials.gov

The Effects of Ferric Derisomaltose on Postoperative Anemia in Spinal Deformity Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Perioperative AnemiaSurgerySpinal DeformityAdult
Interventions
DRUG

Ferric derisomaltose

Single intravenous dose ferric derisomaltose

DRUG

Ferrous succinate

Daily oral dose of 100 mg iron (ferrous succinate) tid postoperatively

Trial Locations (1)

100730

RECRUITING

Peking Union Medical College Hospital, Beijing

Sponsors

Collaborators (1)

Pharmacosmos A/S
All Listed Sponsors
collaborator

Pharmacosmos A/S

INDUSTRY

lead

Peking Union Medical College Hospital

OTHER